Skip to main content

Aries Wealth Management

SEC CIK
0001729515
Latest filing
Jul 24, 2026

AMLX holding history

Amylyx Pharmaceuticals, Inc. in every 13F filed by Aries Wealth Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AMLX overviewAll 13F holders of AMLXFull Q2 2026 holdings

Shares (Q4 2024)
0
Sold out in Q4 2024
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q3 2024
Holdings of AMLX by Aries Wealth Management, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20240$00.0%−15,000−100.0%Sold outHolders
Q3 202415,000$48.6K<0.1%+15,000NewHolders